103 related articles for article (PubMed ID: 25673160)
1. OY-TES-1 may regulate the malignant behavior of liver cancer via NANOG, CD9, CCND2 and CDCA3: a bioinformatic analysis combine with RNAi and oligonucleotide microarray.
Hu Q; Fu J; Luo B; Huang M; Guo W; Lin Y; Xie X; Xiao S
Oncol Rep; 2015 Apr; 33(4):1965-75. PubMed ID: 25673160
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of cancer/testis antigen OY-TES-1 attenuates malignant behaviors of hepatocellular carcinoma cells in vitro.
Fu J; Luo B; Guo WW; Zhang QM; Shi L; Hu QP; Chen F; Xiao SW; Xie XX
Int J Clin Exp Pathol; 2015; 8(7):7786-97. PubMed ID: 26339343
[TBL] [Abstract][Full Text] [Related]
3. Cancer-testis Antigen OY-TES-1 Expression and Immunogenicity in Hepatocellular Carcinoma.
Luo B; Yun X; Li J; Fan R; Guo WW; Liu C; Lin YD; Ge YY; Zeng X; Bi SQ; Nong WX; Zhang QM; Xie XX
Curr Med Sci; 2020 Aug; 40(4):719-728. PubMed ID: 32862383
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of OY-TES-1 by RNAi causes cell cycle arrest and migration decrease in bone marrow-derived mesenchymal stem cells.
Cen YH; Guo WW; Luo B; Lin YD; Zhang QM; Zhou SF; Luo GR; Xiao SW; Xie XX
Cell Biol Int; 2012 Oct; 36(10):917-22. PubMed ID: 22651134
[TBL] [Abstract][Full Text] [Related]
5. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen.
Ono T; Kurashige T; Harada N; Noguchi Y; Saika T; Niikawa N; Aoe M; Nakamura S; Higashi T; Hiraki A; Wada H; Kumon H; Old LJ; Nakayama E
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3282-7. PubMed ID: 11248070
[TBL] [Abstract][Full Text] [Related]
6. Cell-cycle regulator Cks1 promotes hepatocellular carcinoma by supporting NF-κB-dependent expression of interleukin-8.
Lee EK; Kim DG; Kim JS; Yoon Y
Cancer Res; 2011 Nov; 71(21):6827-35. PubMed ID: 21917729
[TBL] [Abstract][Full Text] [Related]
7. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
8. OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer.
Tammela J; Uenaka A; Ono T; Noguchi Y; Jungbluth AA; Mhawech-Fauceglia P; Qian F; Schneider S; Sharma S; Driscoll D; Lele S; Old LJ; Nakayama E; Odunsi K
Int J Oncol; 2006 Oct; 29(4):903-10. PubMed ID: 16964386
[TBL] [Abstract][Full Text] [Related]
9. Translating bioinformatics in oncology: guilt-by-profiling analysis and identification of KIF18B and CDCA3 as novel driver genes in carcinogenesis.
Itzel T; Scholz P; Maass T; Krupp M; Marquardt JU; Strand S; Becker D; Staib F; Binder H; Roessler S; Wang XW; Thorgeirsson S; Müller M; Galle PR; Teufel A
Bioinformatics; 2015 Jan; 31(2):216-24. PubMed ID: 25236463
[TBL] [Abstract][Full Text] [Related]
10. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K
J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
[TBL] [Abstract][Full Text] [Related]
11. The HOX gene network in hepatocellular carcinoma.
Cillo C; Schiavo G; Cantile M; Bihl MP; Sorrentino P; Carafa V; D' Armiento M; Roncalli M; Sansano S; Vecchione R; Tornillo L; Mori L; De Libero G; Zucman-Rossi J; Terracciano L
Int J Cancer; 2011 Dec; 129(11):2577-87. PubMed ID: 21626505
[TBL] [Abstract][Full Text] [Related]
12. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
[TBL] [Abstract][Full Text] [Related]
13. miR-224 promotion of cell migration and invasion by targeting Homeobox D 10 gene in human hepatocellular carcinoma.
Li Q; Ding C; Chen C; Zhang Z; Xiao H; Xie F; Lei L; Chen Y; Mao B; Jiang M; Li J; Wang D; Wang G
J Gastroenterol Hepatol; 2014 Apr; 29(4):835-42. PubMed ID: 24219032
[TBL] [Abstract][Full Text] [Related]
14. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
Zhang C; Guo F; Xu G; Ma J; Shao F
Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
[TBL] [Abstract][Full Text] [Related]
15. [Expression of MAGE, GAGE, and BAGE genes in human hepatocellular carcinoma].
Shao JB; Chen Z
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):142-4. PubMed ID: 12681058
[TBL] [Abstract][Full Text] [Related]
16. Slug promotes hepatocellular cancer cell progression by increasing sox2 and nanog expression.
Zhao X; Sun B; Sun D; Liu T; Che N; Gu Q; Dong X; Li R; Liu Y; Li J
Oncol Rep; 2015 Jan; 33(1):149-56. PubMed ID: 25339068
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of NANOG enhances chemosensitivity of liver cancer cells to doxorubicin by reducing MDR1 expression.
Zhou JJ; Deng XG; He XY; Zhou Y; Yu M; Gao WC; Zeng B; Zhou QB; Li ZH; Chen RF
Int J Oncol; 2014 Jun; 44(6):2034-40. PubMed ID: 24647772
[TBL] [Abstract][Full Text] [Related]
18. Gene network analysis leads to functional validation of pathways linked to cancer cell growth and survival.
Berger E; Vega N; Vidal H; Geloën A
Biotechnol J; 2012 Nov; 7(11):1395-404. PubMed ID: 22930530
[TBL] [Abstract][Full Text] [Related]
19. miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened.
Huang XH; Chen JS; Wang Q; Chen XL; Wen L; Chen LZ; Bi J; Zhang LJ; Su Q; Zeng WT
J Pathol; 2011 Nov; 225(3):463-72. PubMed ID: 21671467
[TBL] [Abstract][Full Text] [Related]
20. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y
J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
